Erasca Newsroom

Jefferies Initiates Erasca(ERAS.US) With Buy Rating, Announces Target Price $6

Moomoo NewsNov 19 03:39 ET

Erasca Initiated at Buy by Jefferies

Dow JonesNov 18 07:25 ET

Erasca Analyst Ratings

BenzingaNov 18 07:15 ET

Bank of America Securities Sticks to Its Hold Rating for Erasca (ERAS)

TipRanksNov 15 09:34 ET

BofA Securities Maintains Erasca(ERAS.US) With Hold Rating

Moomoo NewsNov 15 09:33 ET

Morgan Stanley Maintains Erasca(ERAS.US) With Buy Rating, Maintains Target Price $4

Moomoo NewsNov 13 08:31 ET

H.C. Wainwright Maintains Erasca(ERAS.US) With Buy Rating, Maintains Target Price $6

Moomoo NewsNov 13 07:35 ET

Erasca Analyst Ratings

BenzingaNov 13 07:16 ET

HC Wainwright & Co. Reiterates Buy on Erasca, Maintains $6 Price Target

BenzingaNov 13 07:14 ET

Erasca's Innovative Naporafenib Shows Promise in NRAS-mutant Melanoma, Garnering Buy Rating From Analyst

TipRanksNov 13 06:51 ET

Erasca Price Target Raised to $3.50/Share From $3.00 by Goldman Sachs

Dow JonesOct 25 12:25 ET

Erasca Is Maintained at Buy by Goldman Sachs

Dow JonesOct 25 12:25 ET

A Quick Look at Today's Ratings for Erasca(ERAS.US), With a Forecast Between $4 to $6

Moomoo NewsOct 25 09:10 ET

Erasca Analyst Ratings

BenzingaOct 25 06:29 ET

HC Wainwright & Co. Reiterates Buy on Erasca, Maintains $6 Price Target

BenzingaOct 25 06:29 ET

Erasca's Promising Developments and Positive Outlook Justify Buy Rating

TipRanksOct 25 06:20 ET

Erasca Price Target Raised to $6.00/Share From $5.00 by HC Wainwright & Co.

Dow JonesAug 13 14:24 ET

Erasca Analyst Ratings

BenzingaAug 13 14:14 ET

Erasca Inc. Poised for Growth: Buy Rating Maintained Amidst Promising Trial Updates and Solid Financials

TipRanksAug 13 13:37 ET

Goldman Sachs Maintains Erasca(ERAS.US) With Buy Rating, Cuts Target Price to $3

Moomoo NewsAug 13 13:32 ET